The projected cost of metformin treatment for seven patients with prediabetes can avoid the cost of treating a non-complicated diabetic patient with metformin + glimepiride after 2.9 years; with metformin + DPP4 inhibitors after 2.6 years; and with metformin + insulin after 1.9 years. The gene discussed is INS; the disease is prediabetes syndrome.